Amisulpride Hydrochloride ndopril Although originally described as 100-fold

Although originally described as 100-fold selective for GluN1/GluN2A receptors vs

Smiles: C[C@@H]1C[C@@H]2CC[C@@H]3O[C@H](CC3=C)CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@@H](CC(=O)C[C@@H]7[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]7C[C@@H](O2)C1=C)CC[C@@H]3O[C@H]6[C@H]5O4

Mendiratta S

Food and Drug Administration (FDA) in late May 2007

Smiles: CNC(=O)C1=CC(=CC=C1)C1=CC=C2C(=N1)N=C(N=C2N1CCOC[C@@H]1C)N1CCOC[C@@H]1C

Amisulpride Hydrochloride ndopril Although originally described as 100-foldAmisulpride is an atypical antipsychotic used to treat psychosis in schizophrenia and episodes of mania in bipolar disorder. In Italy, it is also used as a treatment for dysthymia. It was introduced by Sanofi Aventis in the 1990s. Its patent had expired by 2008 and hence generic formulations are now available. Amisulpride function primarily as a D2 and D3 receptor antagonist. It has high affinity for these receptors with dissociation constants of 2. 2